Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (PINL:AMPE)

Research Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Marinus Pharma, Emergent BioSolutions and Ampio Pharma

PR Newswire October 10, 2016

Ampio Announces Accepted Publication of the Clinical Trial Results of Its Oral Drug, Optina™, Treatment of Diabetic Macular Edema

PR Newswire October 4, 2016

Ampio Updates Clinical and Regulatory Activity

PR Newswire September 29, 2016

Ampio Reports Additional Peer-Reviewed Publication on Ampion™

PR Newswire August 30, 2016

Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering

PR Newswire August 29, 2016

10 Biggest Mid-Day Losers For Thursday

Benzinga.com  June 30, 2016

Ampio announces results of Ampion™ trials

PR Newswire June 30, 2016

Ampio Launches Clinical Trial of AMPION™ for the Treatment of Osteoarthritis of the Hand

PR Newswire May 10, 2016

Ampio Reports Additional Peer-Reviewed Publications on Ampion™

PR Newswire May 3, 2016

Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION(TM)

PR Newswire March 29, 2016

Ampio Clarifies ATM Program

PR Newswire February 11, 2016

Ampio's OptimEyes Study Results to be presented at The Association for Research in Vision and Ophthalmology (ARVO)

PR Newswire January 26, 2016

Ampio Announces 2016 Corporate Update on Thursday, January 28, 4:30pm EST

PR Newswire January 25, 2016

Ampio's OptimEyes Study Results to be presented at World Ophthalmology Congress

PR Newswire January 11, 2016

How it All Plays Out - Free Research Reports on Hill International, Marinus Pharmaceuticals, Ampio Pharmaceuticals and Cutera

Accesswire December 18, 2015

The NYSE Establishes January 5, 2016 as the Ex-Distribution Date for the Ampio Distribution of Aytu BioScience Stock to Ampio Shareholders

PR Newswire December 1, 2015

Equity Market Movement at a Glance - Research on AxoGen, Ampio Pharmaceuticals, Ultra Clean Holdings and Willbros Group

Accesswire November 23, 2015

Aytu BioScience to Benefit from Share Distribution by Ampio Pharmaceuticals

PR Newswire November 19, 2015

Ampio Announces Investor Call on its Aytu BioScience Common Stock Distribution on Thursday, November 19, 4:15 p.m. EST

PR Newswire November 18, 2015

Ampio Intends to Distribute Aytu BioScience Stock to Ampio Shareholders

PR Newswire November 2, 2015